SRBT — Shanrong Biotechnology Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.17m
- $2.04m
- $1.32m
Annual balance sheet for Shanrong Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 July 31st | 2008 July 31st | 2009 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.046 | 0.001 | 0.031 |
Net Total Accounts Receivable | |||
Net Total Receivables | — | — | 0.097 |
Total Inventory | |||
Total Current Assets | 0.046 | 0.001 | 0.128 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.006 | 0 | 0.063 |
Total Assets | 0.052 | 0.001 | 0.191 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Current Liabilities | 0.03 | 0.019 | 4.05 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 0.03 | 0.019 | 4.17 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 0.022 | -0.018 | -3.98 |
Total Liabilities & Shareholders' Equity | 0.052 | 0.001 | 0.191 |
Total Common Shares Outstanding |